Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-22

Clinical Trial Update: Comparison of Efficacy and Safety of Combination Therapy and Monotherapy of Candesartan and Amlodipine for Dose-Finding in Patients With Essential Hypertension [Phase 2]

View source ↗

Summary

This completed Phase 2 study evaluated the efficacy and safety of combining candesartan with amlodipine versus each monotherapy for dose-finding in adults with …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atacand (candesartan)
  • NORVASC (amlodipine besylate)

Snippet

Sponsor: Shin Poong Pharmaceutical Co. Ltd. | Conditions: Essential Hypertension | Phase 2 | Status: COMPLETED